Lambrot Romain, Muczynski Vincent, Lécureuil Charlotte, Angenard Gaëlle, Coffigny Hervé, Pairault Catherine, Moison Delphine, Frydman René, Habert René, Rouiller-Fabre Virginie
Laboratory of Differentiation and Radiobiology of the Gonads, Unit of Gametogenesis and Genotoxicity, Fontenay aux Roses, France.
Environ Health Perspect. 2009 Jan;117(1):32-7. doi: 10.1289/ehp.11146. Epub 2008 Sep 9.
Several studies have described an increasing frequency of male reproductive disorders, which may have a common origin in fetal life and which are hypothesized to be caused by endocrine disruptors. Phthalate esters represent a class of environmental endocrine-active chemicals known to disrupt development of the male reproductive tract by decreasing testosterone production in the fetal rat.
Using the organ culture system we developed previously, we investigated the effects on the development of human fetal testis of one phthalate--mono-2-ethylhexyl phthalate (MEHP)--an industrial chemical found in many products, which has been incriminated as a disruptor of male reproductive function.
Human fetal testes were recovered during the first trimester (7-12 weeks) of gestation, a critical period for testicular differentiation, and cultured for 3 days with or without MEHP in basal conditions or stimulated with luteinizing hormone (LH).
Whatever the dose, MEHP treatment had no effect on basal or LH-stimulated testosterone produced by the human fetal testis in vitro, although testosterone production can be modulated in our culture system. MEHP (10(-4) M) did not affect proliferation or apoptosis of Sertoli cells, but it reduced the mRNA expression of anti-Müllerian hormone. MEHP (10(-4) M) reduced the number of germ cells by increasing their apoptosis, measured by the detection of caspase-3-positive germ cells, without modification of their proliferation.
This is the first experimental demonstration that phthalates alter the development of the germ cell lineage in humans. However, in contrast to results observed in the rat, phthalates did not affect steroidogenesis.
多项研究描述了男性生殖系统疾病的发病率不断上升,这些疾病可能在胎儿期有共同的起源,据推测是由内分泌干扰物引起的。邻苯二甲酸酯是一类环境内分泌活性化学物质,已知会通过降低胎鼠体内睾酮的产生来干扰雄性生殖道的发育。
利用我们先前开发的器官培养系统,我们研究了一种邻苯二甲酸酯——单-2-乙基己基邻苯二甲酸酯(MEHP)——对人类胎儿睾丸发育的影响。MEHP是一种在许多产品中都能找到的工业化学品,被认为是男性生殖功能的干扰物。
在妊娠早期(7-12周)获取人类胎儿睾丸,这是睾丸分化的关键时期,在基础条件下或用促黄体生成素(LH)刺激的情况下,将其在有或没有MEHP的条件下培养3天。
无论剂量如何,MEHP处理对体外培养的人类胎儿睾丸产生的基础睾酮或LH刺激的睾酮均无影响,尽管在我们的培养系统中睾酮的产生可以被调节。MEHP(10⁻⁴ M)不影响支持细胞的增殖或凋亡,但它降低了抗苗勒管激素的mRNA表达。MEHP(10⁻⁴ M)通过增加生殖细胞的凋亡来减少生殖细胞数量,这是通过检测caspase-3阳性生殖细胞来衡量的,而其增殖没有改变。
这是邻苯二甲酸酯改变人类生殖细胞谱系发育的首个实验证明。然而,与在大鼠中观察到的结果相反,邻苯二甲酸酯不影响类固醇生成。